Risiglione 2022 Life (Basel)

From Bioblast
Revision as of 14:04, 22 November 2022 by Plangger Mario (talk | contribs) (Created page with "{{Publication |title=Risiglione P, Cubisino SAM, Lipari CLR, De Pinto V, Messina A, Magrì A (2022) α-Synuclein A53T promotes mitochondrial proton gradient dissipation and de...")
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)
Publications in the MiPMap
Risiglione P, Cubisino SAM, Lipari CLR, De Pinto V, Messina A, Magrì A (2022) α-Synuclein A53T promotes mitochondrial proton gradient dissipation and depletion of the organelle respiratory reserve in a neuroblastoma cell line. https://doi.org/10.3390/life12060894

Β» Life (Basel) 12:894. PMID: 35743925 Open Access

Risiglione Pierpaolo,  Cubisino Salvatore Antonio Maria, Lipari Cristiana Lucia Rita,  De Pinto Vito, Messina Angela, Magri Andrea (2022) Life (Basel)

Abstract: Ξ±-synuclein (Ξ±Syn) is a small neuronal protein whose accumulation correlates with Parkinson's disease. Ξ±Syn A53T mutant impairs mitochondrial functions by affecting substrate import within the organelle, activity of complex I and the maximal respiratory capacity. However, the precise mechanism initiating the bioenergetic dysfunction is not clearly understood yet. By overexpressing Ξ±Syn A53T in SH-SY5Y cells, we investigated the specific changes in the mitochondrial respiratory profile using High-Resolution Respirometry. We found that Ξ±Syn A53T increases dissipative fluxes across the intermembrane mitochondrial space: this does not compromise the oxygen flows devoted to ATP production while it reduces the bioenergetic excess capacity of mitochondria, providing a possible explanation of the increased cell susceptibility observed in the presence of further stress stimuli. β€’ Keywords: Parkinson’s disease, High-resolution respirometry, Mitochondrial dysfunction, Ξ±Syn β€’ Bioblast editor: Plangger M


Labels: MiParea: Respiration  Pathology: Parkinson's 





HRR: Oxygraph-2k 

2022-11 

Cookies help us deliver our services. By using our services, you agree to our use of cookies.